Search research articles
Contact Us
Filters
Showing results (111-120 of 142) with videos related to
Page
of 15
Sort By:
Cancer Immunology Research
|
August 6, 2017
Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy
Kerstin Wennhold, Martin Thelen, Hans Anton Schlößer, et al.
Oncogene
|
March 3, 2020
ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells
Enric Redondo Monte, Anja Wilding, Georg Leubolt, et al.
Theranostics
|
September 20, 2019
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53
Maximiliane Schuldner, Bastian Dörsam, Olga Shatnyeva, et al.
Journal of Leukocyte Biology
|
August 19, 2016
Antigen-presenting human B cells are expanded in inflammatory conditions
Alexander Shimabukuro-Vornhagen, María García-Márquez, Rieke N Fischer, et al.
Cell
|
August 28, 2016
Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity
Alexander Jais, Maite Solas, Heiko Backes, et al.
Cell
|
May 3, 2016
Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity
Alexander Jais, Maite Solas, Heiko Backes, et al.
Oncotarget
|
June 3, 2017
Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma
Axel Lechner, Hans Schlößer, Sacha I Rothschild, et al.
Nature Biomedical Engineering
|
June 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyond
Mar Guaza-Lasheras, Johanna Nimmerfroh, Dominic Schwarz, et al.
Nature Communications
|
October 27, 2023
Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming
Hao Wu, Xiufeng Zhao, Sophia M Hochrein, et al.
Cancer Immunology Research
|
July 29, 2016
Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
Sebastian Theurich, Sacha I Rothschild, Michael Hoffmann, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 142) with videos related to
Sort By:
Page
of 15
Cancer Immunology Research
|
August 6, 2017
Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy
Kerstin Wennhold, Martin Thelen, Hans Anton Schlößer, et al.
Oncogene
|
March 3, 2020
ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells
Enric Redondo Monte, Anja Wilding, Georg Leubolt, et al.
Theranostics
|
September 20, 2019
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53
Maximiliane Schuldner, Bastian Dörsam, Olga Shatnyeva, et al.
Journal of Leukocyte Biology
|
August 19, 2016
Antigen-presenting human B cells are expanded in inflammatory conditions
Alexander Shimabukuro-Vornhagen, María García-Márquez, Rieke N Fischer, et al.
Cell
|
August 28, 2016
Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity
Alexander Jais, Maite Solas, Heiko Backes, et al.
Cell
|
May 3, 2016
Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity
Alexander Jais, Maite Solas, Heiko Backes, et al.
Oncotarget
|
June 3, 2017
Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma
Axel Lechner, Hans Schlößer, Sacha I Rothschild, et al.
Nature Biomedical Engineering
|
June 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyond
Mar Guaza-Lasheras, Johanna Nimmerfroh, Dominic Schwarz, et al.
Nature Communications
|
October 27, 2023
Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming
Hao Wu, Xiufeng Zhao, Sophia M Hochrein, et al.
Cancer Immunology Research
|
July 29, 2016
Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
Sebastian Theurich, Sacha I Rothschild, Michael Hoffmann, et al.
Page
of 15